All In Biotech

Drug Trial Radar · NCT05295173

A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)

A Phase III, Multicenter, Randomized, Blind Endpoint and Positive Drug Control Study of Recombinant Human Tissue Plasminogen Kinase Derivatives for Injection in the Treatment of Patients With Acute Ischemic Stroke

Last checked: Nov 20, 2026Latest source record: Mar 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,412 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,412

Actual

Start

Mar 21, 2022

Primary completion

Jun 22, 2023

Study completion Jun 22, 2023

Sponsor

Sponsor type
Industry
Collaborators
Beijing Tiantan Hospital
First posted
Mar 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of recombinant human tissue plasminogen kinase derivatives for injection and alteplase in the treatment of patients with acute ischemic stroke within 4.5 hours.

Conditions

  • Acute Ischemic Stroke

Interventions

  • Injection of recombinant human tissue plasminogen kinase derivativesDrug

    18mg/10ml/stick, provided by Angde Biotech

  • Recombinant human tissue plasminogen activatorDrug

    20mg/stick, 50mg/stick, provided by Shanghai Boehringer Ingelheim Pharmaceutical Co. Ltd.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Functional handicapTime frame: on the 90th day after treatment

Locations

78 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China

  • Xuanwu Hospital of Capital Medical University

    Beijing, Beijing Municipality, China

  • Beijing Tiantan Hospital

    Beijing, Beijing Municipality, China

  • Chongqing Emergency Medical Center

    Chongqing, Chongqing Municipality, China

  • Gaozhou People's Hospital

    Gaozhou, Guangdong, China

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China

  • Meizhou People's Hospital

    Meizhou, Guangdong, China

  • Yue Bei People's Hospital

    Shaoguan, Guangdong, China

  • Zhuhai People's Hospital

    Zhuhai, Guangdong, China

  • Cangzhou Central Hospital

    Cangzhou, Hebei, China

  • Hebei Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine

    Cangzhou, Hebei, China

  • Handan Central Hospital

    Handan, Hebei, China

  • Hengshui People's Hospital

    Hengshui, Hebei, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • The First Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Tangshan Workers'Hospital

    Tangshan, Hebei, China

  • Daqing Oilfield General Hospital

    Daqing, Heilongjiang, China

  • Daqing People's Hospital

    Daqing, Heilongjiang, China

  • The Fourth Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China

  • The Third Affiliated Hospital of Qiqihar Medical College

    Qiqihar, Heilongjiang, China

  • Anyang People's Hospital

    Anyang, Henan, China

  • Jiaozuo People's Hospital

    Jiaozuo, Henan, China

  • Huaihe Hospital of Henan University

    Kaifeng, Henan, China

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyan, Henan, China

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China

  • Luoyang Central Hospital

    Luoyang, Henan, China

  • Nanyang Nanshi Hospital

    Nanyang, Henan, China

  • Nanyang Second People's Hospital

    Nanyang, Henan, China

  • Xinxiang Central Hospital

    Xinxiang, Henan, China

  • Zhengzhou People's Hospital

    Zhengzhou, Henan, China

  • Zhumadian Central Hospital

    Zhumadian, Henan, China

  • Wuhan Fourth Hospital (Wuhan Puai Hospital, Wuhan Orthopaedic Hospital)

    Wuhan, Hubei, China

  • The First Affiliated Hospital of Nanhua University

    Hengyang, Hunan, China

  • Yiyang Central Hospital

    Yiyang, Hunan, China

  • Inner Mongolia Baogang Hospital

    Baotou, Inner Mongolia, China

  • The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

    Baotou, Inner Mongolia, China

  • Inner Mongolia Autonomous Region People's Hospital

    Hohhot, Inner Mongolia, China

  • Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China

  • Huai'an Second People's Hospital

    Huai'an, Jiangsu, China

  • Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.